Skip to main content
SpringerLink
Log in

MULTIPLE SCLEROSIS

Ageing reduces potential for remyelination in multiple sclerosis

  • Research Highlight
  • Published:

From Nature Reviews Neurology

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

Original article

Related articles

  • Brown, J. W. L. et al. Safety and efficacy of bexarotene in patients with relapsing–remitting multiple sclerosis (CCMR One): a randomised, double-blind, placebo-controlled, parallel-group, phase 2a study. Lancet Neurol. 9, 709–720 (2021)

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Nature Reviews Neurology http://www.nature.com/nrneurol/

    Ian Fyfe

Authors
  1. Ian Fyfe
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ian Fyfe.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fyfe, I. Ageing reduces potential for remyelination in multiple sclerosis. Nat Rev Neurol 18, 381 (2022). https://doi.org/10.1038/s41582-022-00680-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41582-022-00680-3

  • Springer Nature Limited

Search

Navigation